FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897566843> ?p ?o ?g. }

• W2897566843 endingPage "7052" @default.
• W2897566843 startingPage "7041" @default.
• W2897566843 abstract "Acute myeloid leukemia (AML) is a highly heterogeneous disease. Mutation with internal tandem duplication of fms-like tyrosine kinase-3 (FLT3-ITD) is one of the two most common driver mutations and the presence of FLT3-ITD delivers poor prognosis. A number of ongoing clinical efforts are focused on FLT3 inhibitor use to improve the outcomes of this otherwise difficult leukemia. Midostaurin has been shown to improve outcomes in FLT3-mutated AML in the frontline setting. Several FLT3 inhibitors, especially second-generation agents, have shown clinically meaningful activity in relapsed or refractory AML and in patients not amenable to intensive therapy. In this article, we briefly review the biology of FLT3 in the physiological state and its role in leukemogenesis. We present a detailed review of current clinical evidence of FLT3 inhibitors and their use in the induction, treatment of relapsed or refractory disease, and maintenance setting." @default.
• W2897566843 created "2018-10-26" @default.
• W2897566843 creator A5056737997 @default.
• W2897566843 creator A5086805182 @default.
• W2897566843 date "2018-10-01" @default.
• W2897566843 modified "2023-10-14" @default.
• W2897566843 title "Clinical use of FLT3 inhibitors in acute myeloid leukemia" @default.
• W2897566843 cites W1506423591 @default.
• W2897566843 cites W1592701464 @default.
• W2897566843 cites W1744167954 @default.
• W2897566843 cites W1937648101 @default.
• W2897566843 cites W1971833736 @default.
• W2897566843 cites W1974674483 @default.
• W2897566843 cites W1978495299 @default.
• W2897566843 cites W1982197818 @default.
• W2897566843 cites W1984712646 @default.
• W2897566843 cites W1990870968 @default.
• W2897566843 cites W1993300766 @default.
• W2897566843 cites W2016883830 @default.
• W2897566843 cites W2029056941 @default.
• W2897566843 cites W2033350541 @default.
• W2897566843 cites W2038824910 @default.
• W2897566843 cites W2042382807 @default.
• W2897566843 cites W2048369203 @default.
• W2897566843 cites W2070609585 @default.
• W2897566843 cites W2073788073 @default.
• W2897566843 cites W2074487662 @default.
• W2897566843 cites W2080059445 @default.
• W2897566843 cites W2097583774 @default.
• W2897566843 cites W2106533048 @default.
• W2897566843 cites W2109078622 @default.
• W2897566843 cites W2112414163 @default.
• W2897566843 cites W2131557977 @default.
• W2897566843 cites W2132912591 @default.
• W2897566843 cites W2147338626 @default.
• W2897566843 cites W2154625299 @default.
• W2897566843 cites W2164886552 @default.
• W2897566843 cites W2171484579 @default.
• W2897566843 cites W2199445282 @default.
• W2897566843 cites W2200839210 @default.
• W2897566843 cites W2208333084 @default.
• W2897566843 cites W2339658711 @default.
• W2897566843 cites W2419140434 @default.
• W2897566843 cites W2553392785 @default.
• W2897566843 cites W2559537906 @default.
• W2897566843 cites W2586257925 @default.
• W2897566843 cites W2613275252 @default.
• W2897566843 cites W2617622088 @default.
• W2897566843 cites W2654449699 @default.
• W2897566843 cites W2715749014 @default.
• W2897566843 cites W2783970986 @default.
• W2897566843 doi "https://doi.org/10.2147/ott.s171640" @default.
• W2897566843 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6198878" @default.
• W2897566843 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30410361" @default.
• W2897566843 hasPublicationYear "2018" @default.
• W2897566843 type Work @default.
• W2897566843 sameAs 2897566843 @default.
• W2897566843 citedByCount "28" @default.
• W2897566843 countsByYear W28975668432019 @default.
• W2897566843 countsByYear W28975668432020 @default.
• W2897566843 countsByYear W28975668432021 @default.
• W2897566843 countsByYear W28975668432022 @default.
• W2897566843 countsByYear W28975668432023 @default.
• W2897566843 crossrefType "journal-article" @default.
• W2897566843 hasAuthorship W2897566843A5056737997 @default.
• W2897566843 hasAuthorship W2897566843A5086805182 @default.
• W2897566843 hasBestOaLocation W28975668431 @default.
• W2897566843 hasConcept C104317684 @default.
• W2897566843 hasConcept C126322002 @default.
• W2897566843 hasConcept C142424586 @default.
• W2897566843 hasConcept C143998085 @default.
• W2897566843 hasConcept C170493617 @default.
• W2897566843 hasConcept C2776481607 @default.
• W2897566843 hasConcept C2778461978 @default.
• W2897566843 hasConcept C2778729363 @default.
• W2897566843 hasConcept C2779134260 @default.
• W2897566843 hasConcept C2910954276 @default.
• W2897566843 hasConcept C42362537 @default.
• W2897566843 hasConcept C501734568 @default.
• W2897566843 hasConcept C502942594 @default.
• W2897566843 hasConcept C55493867 @default.
• W2897566843 hasConcept C60644358 @default.
• W2897566843 hasConcept C71924100 @default.
• W2897566843 hasConcept C86803240 @default.
• W2897566843 hasConcept C87355193 @default.
• W2897566843 hasConceptScore W2897566843C104317684 @default.
• W2897566843 hasConceptScore W2897566843C126322002 @default.
• W2897566843 hasConceptScore W2897566843C142424586 @default.
• W2897566843 hasConceptScore W2897566843C143998085 @default.
• W2897566843 hasConceptScore W2897566843C170493617 @default.
• W2897566843 hasConceptScore W2897566843C2776481607 @default.
• W2897566843 hasConceptScore W2897566843C2778461978 @default.
• W2897566843 hasConceptScore W2897566843C2778729363 @default.
• W2897566843 hasConceptScore W2897566843C2779134260 @default.
• W2897566843 hasConceptScore W2897566843C2910954276 @default.
• W2897566843 hasConceptScore W2897566843C42362537 @default.
• W2897566843 hasConceptScore W2897566843C501734568 @default.
• W2897566843 hasConceptScore W2897566843C502942594 @default.

• next